Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study)
详细信息    查看全文
文摘
This study tested the effect of oral prednisone on clinical and angiographic restenosis rate after successful stent implantation in patients with persistent elevation of systemic markers of inflammation after the procedure.

Background

Experimental studies have shown that corticosteroids have the potential to reduce the inflammatory response associated with stent implantation.

Methods

Eighty-three patients undergoing successful stenting with C-reactive protein (CRP) levels >0.5 mg/dl 72 h after the procedure were randomized to receive oral prednisone or placebo for 45 days. The primary clinical end point was 12-month event-free survival rate (defined as freedom from death, from myocardial infarction, and from recurrence of symptoms requiring additional revascularization). The angiographic end points were restenosis rate and late loss at six months.

Results

Twelve-month event-free survival rates were 93 % and 65 % in patients treated with prednisone and placebo, respectively (relative risk [RR] 0.18, 95 % confidence intervals [CI], 0.05 to 0.61, P = 0.0063). Six-month restenosis rate and late loss were lower in prednisone-treated than in placebo-treated patients (7 % vs. 33 % , P = 0.001, and 0.39 ± 0.6 mm vs. 0.85 ± 0.6 mm, P = 0.001, respectively).

Conclusions

In patients with persistently high CRP levels after successful coronary artery stent implantation, oral immunosuppressive therapy with prednisone results in a striking reduction of clinical events and angiographic restenosis rate.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700